Mixture solution containing conjugate of transferrin and quercetin and use thereof
A technology of transferrin and mixed solution, which is applied in the direction of medical preparations containing active ingredients, medical preparations with non-active ingredients, drug combinations, etc., can solve the problems of cell toxicity, etc. Mild, less toxic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Add 0.2ml 10×10 to a 5.00ml volumetric flask -4 M quercetin in phosphate buffer solution (pH 7.4), then add 0.4ml 1.25×10 -4 M human transferrin (purchased from Sigma-Aldrich, T3309) in phosphate buffer solution (pH 7.4), the molar concentration ratio of human transferrin and quercetin in the mixed solution is 1:4; The solution was diluted to a quercetin concentration of 40 μM; the mixed solution was shaken evenly and left to stand for 12 hours, and the transferrin reacted with the quercetin to obtain a mixed solution containing a conjugate of the transferrin and quercetin. After UV-Vis absorption spectroscopy analysis, the results are as follows: figure 1 As shown in A, a new absorption peak appeared at 323nm, indicating that quercetin and transferrin interacted to form a conjugate, resulting in characteristic absorption.
[0026] Similarly, after preparing quercetin and human transferrin with pH 4.8 phosphate buffer solution respectively, and then mixing them, the m...
Embodiment 2
[0030] Add 0.2ml 10×10 to a 5.00ml volumetric flask -4 M quercetin in phosphate buffer solution (pH 6.8), then add 0.4ml 1.25×10 -4Phosphate buffer solution (pH 6.8) of M human transferrin (purchased from Sigma-Aldrich Company, T3309), the molar concentration ratio of human transferrin and quercetin in the mixed solution is 1:4; The solution was diluted to a quercetin concentration of 40 μM; the mixed solution was shaken evenly and left to stand for 12 hours, and the transferrin reacted with the quercetin to obtain a mixed solution containing a conjugate of the transferrin and quercetin. The same results as in Example 1 were obtained by UV-visible absorption spectrum, fluorescence spectrum and circular dichroism analysis, that is, the combination of the two under neutral conditions.
Embodiment 3
[0032] Add 0.2ml 10×10 to a 5.00ml volumetric flask -4 M quercetin in phosphate buffer solution (pH 7.8), then add 0.4ml 1.25×10 -4 Phosphate buffer solution (pH 7.8) of human transferrin (purchased from Sigma-Aldrich Company, T3309), the molar concentration ratio of human transferrin and quercetin in the mixed solution is 1:4; The solution was diluted to a quercetin concentration of 40 μM; the mixed solution was shaken evenly and left to stand for 12 hours, and the transferrin reacted with the quercetin to obtain a mixed solution containing a conjugate of the transferrin and quercetin. Through the analysis of ultraviolet-visible absorption spectrum, fluorescence spectrum and circular dichroism spectrum, the same result as in Example 1 was obtained, that is, the combination of the two under neutral conditions.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com